This product is a recombinant Human antibody Fab fragment that can recognize H3N2 HA. H3v-47 exhibits potent cross-reactive neutralization activity against human and swine H3N2 viruses that circulated since 1989. H3v-47 functions primarily by inhibiting viral egress and also effectively engages Fc receptor to elicit ADCC activity. H3v-47 targets a unique conformational epitope spanning the RBS and vestigial esterase region in the HA head mainly using the complementarity determining regions (CDRs) H2 and H3 from the heavy chain and L1 and L3 from the light chain.
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
EPAF-0094LC | Recombinant Mouse Anti-H3N2 HA Antibody (170) | ELISA, WB | IgG2a |
EPAF-0115LC | Recombinant Mouse Anti-H3N2 HA Antibody (203) | ELISA | IgG1 |
EPAF-0120LC | Recombinant Mouse Anti-H3N2 HA Antibody (207) | ELISA | IgG1 |
EPAF-0128LC | Recombinant Mouse Anti-H3N2 HA Antibody (221) | ELISA | IgG2b |
EPAF-0180LC | Recombinant Mouse Anti-H3N2 HA Antibody (261) | ELISA | IgG2a |
There are currently no Customer reviews or questions for PFBC-404. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.